An observational prospective study was conducted by AS Olafsdottir,a GV Skuladottir,b I Thorsdottir,a A Hauksson,c L Steingrimsdottird to investigate the interaction of smoking status and dietary intake during pregnancy and its relationship to maternal weight gain and birth size parameters in four hundred and eight healthy pregnant Icelandic women.
A Cross-sectional study “Seasonal patterns and preterm birth: a systematic review of the literature and an analysis in a London-based cohort” conducted by SJ Lee,a PJ Steer,b V Filippia at Eighteen maternity units in a London health region from 1988 to 2000. The objectives of this study included a systematic review of the countries in which a seasonal pattern of preterm birth has been reported and an analysis on the seasonal variability of preterm birth in a London-based cohort.
Caesarean section rates in Chile are reported to be as high as 60% in some populations. A new study “Chilean women’s preferences regarding mode of delivery: which do they prefer and why?” conducted by ACE Angeja,a AE Washington,a JE Vargas,a R Gomez,b I Rojas,c AB Caugheya. The purpose of this study was to determine pregnant Chilean women’s preferences towards mode of delivery.
To test the null hypothesis that, after 28 weeks of gestation, uterine blood flow during supine rest and supine exercise is no different than uterine blood flow at left-lateral rest, RM Jeffreys,a W Stepanchak,a B Lopez,a,b J Hardis,a JF Clapp IIIa,b,c conducted study in pregnant women at Department of Obstetrics, MetroHealth Medical Center, Cleveland, OH, USA.
Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has granted approval of a new 300 mg single capsule formulation of REYATAZ? (atazanavir sulfate) for the treatment of HIV-1 infection in adults as part of combination therapy. Taken once daily along with ritonavir and food as part of a anti-HIV drug regimen, the REYATAZ 300 mg single capsule formulation can replace two REYATAZ 150 mg capsules for: patients who have previously received anti-HIV medicines, patients who will be receiving tenofovir disoproxil fumarate, and patients who have never taken anti-HIV medicines that require SUSTIVA? (efavirenz) as part of their anti-HIV drug regimen. The REYATAZ single capsule formulation will be available in the United States within seven business days.
Women who carry a common parasite are more likely to give birth to boys, Czech researchers report. In most populations, 51 percent of babies born are male, Dr. S. Kankova of Charles University in Prague and colleagues note. But among a group of women infected with the bug Toxoplasma, 61 percent of babies born were boys.
U.K. fertility experts issued recommendations on Wednesday to reduce the rising number of twin births in cases of in-vitro fertilization, including the transfer of only one embryo into the womb. In a report presented to the nation’s fertility watchdog, the panel of experts said research has shown that limiting the number of embryos transferred can reduce the number of twins born through in-vitro fertilization without changing the overall success rate.
The National Institutes of Health opened a new health information center today at the Jackson Medical Mall in Jackson, Mississippi, affirming NIH?s commitment to providing accurate, up-to-date health information to Mississippi residents.
A woman in her 50s gave birth last year to a baby she had carried for her daughter, who is unable to bear children, the head of a maternity clinic in Nagano Prefecture announced Sunday. The revelation could stir further debate about births by surrogate mothers, which are opposed by both the health ministry and the nation’s obstetrician association.
The drug misoprostol provides a safe, convenient, and inexpensive means to prevent postpartum hemorrhage, a major killer of women in developing countries. The study was conducted by researchers from the University of Missouri, India?s Jawaharlal Nehru Medical College, the National Institutes of Health, and other institutions.